Filtered By:
Infectious Disease: HIV AIDS

This page shows you your search results in order of date. This is page number 3.

Order by Relevance | Date

Total 15008 results found since Jan 2013.

Analysis and comparison of clinical practice guidelines regarding treatment recommendations for chronic tinnitus in adults: a systematic review
Conclusions There were notable differences with respect to whether guidelines considered the available evidence sufficient enough to make a recommendation. Notably, we identified substantial differences in the rigour of guideline design and development. Reporting was poor in many guidelines. Future guidelines could benefit from the use of reporting tools to improve reporting and transparency and the inclusion of guideline experts and patients to improve the quality of clinical practice guidelines on tinnitus.
Source: BMJ Open - September 15, 2023 Category: General Medicine Authors: Meijers, S., Stegeman, I., van der Leun, J. A., Assegaf, S. A., Smit, A. L. Tags: Open access, Ear, nose and throat/otolaryngology Source Type: research

The assessment and management of voiding dysfunction in adults living with cerebral palsy
ConclusionManagement of NLUTD in adults with CP involves conservative management, medications, and in rare cases surgical intervention.
Source: World Journal of Urology - September 14, 2023 Category: Urology & Nephrology Source Type: research

Severity in schizophrenia patients receiving atypical antipsychotic medications
Bioinformation. 2022 Dec 31;18(12):1154-1158. doi: 10.6026/973206300181154. eCollection 2022.ABSTRACTAtypical antipsychotic drugs are nowadays the mainstay of treatment of schizophrenia due to their lesser extrapyramidal symptoms (EPS) as adverse effects. However, these drugs have different profiles of adverse drug reactions (ADRs). Here, the objective of this study was to analyze the probability, occurrences, and more significant involvement of various risk factors. A prospective observational study was carried out on a patient with schizophrenia who has prescribed atypical antipsychotic drugs for their treatment. The pro...
Source: Bioinformation - September 13, 2023 Category: Bioinformatics Authors: Syed Meraj Alam Fatmi J Rakesh Koul Prakash Suruchi Sheenam Ayub Source Type: research

Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa
CONCLUSION: TFV-DP in DBS showed a step-wise inverse relationship with VB and drug resistance, with evidence of low cumulative ART adherence in PWH who developed antiretroviral resistance. Monitoring TFV-DP concentrations could be a valuable tool for predicting future VB and future resistance.PMID:37705102 | PMC:PMC10500931 | DOI:10.1186/s12981-023-00552-w
Source: AIDS Research and Therapy - September 13, 2023 Category: Infectious Diseases Authors: Y Singh J Castillo-Mancilla R Madimabe L Jennings C M Ferraris R N Robbins P L Anderson R H Remien C Orrell Source Type: research

Severity in schizophrenia patients receiving atypical antipsychotic medications
Bioinformation. 2022 Dec 31;18(12):1154-1158. doi: 10.6026/973206300181154. eCollection 2022.ABSTRACTAtypical antipsychotic drugs are nowadays the mainstay of treatment of schizophrenia due to their lesser extrapyramidal symptoms (EPS) as adverse effects. However, these drugs have different profiles of adverse drug reactions (ADRs). Here, the objective of this study was to analyze the probability, occurrences, and more significant involvement of various risk factors. A prospective observational study was carried out on a patient with schizophrenia who has prescribed atypical antipsychotic drugs for their treatment. The pro...
Source: Bioinformation - September 13, 2023 Category: Bioinformatics Authors: Syed Meraj Alam Fatmi J Rakesh Koul Prakash Suruchi Sheenam Ayub Source Type: research

CROI 2023: Metabolic and Other Complications of HIV Infection
Top Antivir Med. 2023 Jun 30;31(4):538-542.ABSTRACTComorbid conditions have major impacts on the health, quality of life, and survival of people with HIV, particularly as they age. The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) featured excellent science related to specific comorbidities, such as cardiovascular disease (CVD), cancer, and obesity. Studies investigating factors that may contribute to CVD, such as mental health disorders, antiretroviral therapies, and activation of hormonal pathways, were featured prominently. Other studies sought to understand the epidemiology of non-AIDS-defining ca...
Source: Topics in HIV Medicine - September 13, 2023 Category: Infectious Diseases Authors: Sudipa Sarkar Todd T Brown Source Type: research

CROI 2023: Summary of Basic Science Research in HIV
Top Antivir Med. 2023 Jun 30;31(4):523-528.ABSTRACTThe 2023 Conference on Retroviruses and Opportunistic Infections (CROI) represented the first fully in-person conference since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic began. CROI continues as the premier conference in which delegates can appraise themselves of almost every facet of HIV/AIDS research as well as emerging and re-emerging pathogens such as SARS-CoV-2 and mpox. The return to an in-person format is particularly important for early-stage investigators, who were faced with challenges of advancing their independent research careers...
Source: Topics in HIV Medicine - September 13, 2023 Category: Infectious Diseases Authors: Mario Stevenson Source Type: research

Tenofovir diphosphate in dried blood spots and HIV-1 resistance in South Africa
CONCLUSION: TFV-DP in DBS showed a step-wise inverse relationship with VB and drug resistance, with evidence of low cumulative ART adherence in PWH who developed antiretroviral resistance. Monitoring TFV-DP concentrations could be a valuable tool for predicting future VB and future resistance.PMID:37705102 | DOI:10.1186/s12981-023-00552-w
Source: AIDS Research and Therapy - September 13, 2023 Category: Infectious Diseases Authors: Y Singh J Castillo-Mancilla R Madimabe L Jennings C M Ferraris R N Robbins P L Anderson R H Remien C Orrell Source Type: research

Severity in schizophrenia patients receiving atypical antipsychotic medications
Bioinformation. 2022 Dec 31;18(12):1154-1158. doi: 10.6026/973206300181154. eCollection 2022.ABSTRACTAtypical antipsychotic drugs are nowadays the mainstay of treatment of schizophrenia due to their lesser extrapyramidal symptoms (EPS) as adverse effects. However, these drugs have different profiles of adverse drug reactions (ADRs). Here, the objective of this study was to analyze the probability, occurrences, and more significant involvement of various risk factors. A prospective observational study was carried out on a patient with schizophrenia who has prescribed atypical antipsychotic drugs for their treatment. The pro...
Source: Bioinformation - September 13, 2023 Category: Bioinformatics Authors: Syed Meraj Alam Fatmi J Rakesh Koul Prakash Suruchi Sheenam Ayub Source Type: research

CROI 2023: Metabolic and Other Complications of HIV Infection
Top Antivir Med. 2023 Jun 30;31(4):538-542.ABSTRACTComorbid conditions have major impacts on the health, quality of life, and survival of people with HIV, particularly as they age. The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) featured excellent science related to specific comorbidities, such as cardiovascular disease (CVD), cancer, and obesity. Studies investigating factors that may contribute to CVD, such as mental health disorders, antiretroviral therapies, and activation of hormonal pathways, were featured prominently. Other studies sought to understand the epidemiology of non-AIDS-defining ca...
Source: Topics in HIV Medicine - September 13, 2023 Category: Infectious Diseases Authors: Sudipa Sarkar Todd T Brown Source Type: research

CROI 2023: Summary of Basic Science Research in HIV
Top Antivir Med. 2023 Jun 30;31(4):523-528.ABSTRACTThe 2023 Conference on Retroviruses and Opportunistic Infections (CROI) represented the first fully in-person conference since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic began. CROI continues as the premier conference in which delegates can appraise themselves of almost every facet of HIV/AIDS research as well as emerging and re-emerging pathogens such as SARS-CoV-2 and mpox. The return to an in-person format is particularly important for early-stage investigators, who were faced with challenges of advancing their independent research careers...
Source: Topics in HIV Medicine - September 13, 2023 Category: Infectious Diseases Authors: Mario Stevenson Source Type: research

CROI 2023: Metabolic and Other Complications of HIV Infection
Top Antivir Med. 2023 Jun 30;31(4):538-542.ABSTRACTComorbid conditions have major impacts on the health, quality of life, and survival of people with HIV, particularly as they age. The 2023 Conference on Retroviruses and Opportunistic Infections (CROI) featured excellent science related to specific comorbidities, such as cardiovascular disease (CVD), cancer, and obesity. Studies investigating factors that may contribute to CVD, such as mental health disorders, antiretroviral therapies, and activation of hormonal pathways, were featured prominently. Other studies sought to understand the epidemiology of non-AIDS-defining ca...
Source: Topics in HIV Medicine - September 13, 2023 Category: Infectious Diseases Authors: Sudipa Sarkar Todd T Brown Source Type: research

CROI 2023: Summary of Basic Science Research in HIV
Top Antivir Med. 2023 Jun 30;31(4):523-528.ABSTRACTThe 2023 Conference on Retroviruses and Opportunistic Infections (CROI) represented the first fully in-person conference since the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) pandemic began. CROI continues as the premier conference in which delegates can appraise themselves of almost every facet of HIV/AIDS research as well as emerging and re-emerging pathogens such as SARS-CoV-2 and mpox. The return to an in-person format is particularly important for early-stage investigators, who were faced with challenges of advancing their independent research careers...
Source: Topics in HIV Medicine - September 13, 2023 Category: Infectious Diseases Authors: Mario Stevenson Source Type: research

Severity in schizophrenia patients receiving atypical antipsychotic medications
Bioinformation. 2022 Dec 31;18(12):1154-1158. doi: 10.6026/973206300181154. eCollection 2022.ABSTRACTAtypical antipsychotic drugs are nowadays the mainstay of treatment of schizophrenia due to their lesser extrapyramidal symptoms (EPS) as adverse effects. However, these drugs have different profiles of adverse drug reactions (ADRs). Here, the objective of this study was to analyze the probability, occurrences, and more significant involvement of various risk factors. A prospective observational study was carried out on a patient with schizophrenia who has prescribed atypical antipsychotic drugs for their treatment. The pro...
Source: Bioinformation - September 13, 2023 Category: Bioinformatics Authors: Syed Meraj Alam Fatmi J Rakesh Koul Prakash Suruchi Sheenam Ayub Source Type: research